crystalline or porous freeze-dried mass of living microbial cells of Bacillus subtilis UKM In-5007 and Bacillus licheniformis UKM in-5514 from light gray to beige or dark gray (perhaps with light - or dark-brown hue), with specific odour and sweetish taste.
Qualitative and quantitative composition
Active ingredients: one dose Biosporin-Biopharma contains live microbial cells of Bacillus subtilis UKM In-5007 and Bacillus licheniformis UKM In-5514- 1,1-109 - 10-109.
Excipients: sucrose ( or crystalline), gelatin, sodium chloride.
Powder for oral suspension.
Code PBX. A07FA50**. Antidiarrheal of microbial preparations.
Immunological and biological properties
Shows high antagonistic activity against pathogenic and conditionally pathogenic microorganisms, does not affect normal microflora representatives. Synthesizes complex of enzymes that stimulate and regulate digestion and contribute to a better digestion.
Indications for use
Biosporin-Biopharma is designed for the treatment of children (from 3 months) and adults:
•patients with acute intestinal infections (aII) light and medium forms and severe forms in patients with contraindications to antibiotic therapy), caused by pathogenic and opportunistic pathogens (including antibiotic-resistant) microorganisms (Salmonella spp., Shigella spp. enteropathogenesis E. coli, Proteus spp., Staphylococcus spp., Candida spp.);
•persons who have suffered from OKA (in the case of isolation of pathogenic and conditionally pathogenic microorganisms, as well as dysfunction of the bowel);
•for correction of intestinal microflora (in dysbacterioses arising as a result of antibiotic treatment or other reasons);
•with the purpose of prophylaxis of purulent-septic complications in the postoperative period;
•in gynecological practice: when vulvowaginalnom candidiasis in women of reproductive age including pregnant women, at bacterial vagos (with the goal of rehabilitation after the course of antibiotic therapy);
•in dental practice in chronic recurrent stomatitis in children.
Method of application and doses
The drug is used in suspension. To obtain suspen drug use boiled water at room temperature.
1.In a glass pour water from calculation 1 teaspoon on 1 dose (number of doses indicated on the label).
2.For drug dissolution, water (1-2 teaspoons) of glass poured into the vial and stirred. Within 1-2 minutes. formed a homogeneous suspension, from light gray to beige or dark gray (maybe with light or dark brown tinge).
3.The dissolved drug from the vial is poured into the glass with the remainder of water and mix thoroughly.
1 teaspoon in a glass of solution is equal to 1 dose of the drug.
If the bottle contains 1 dose of the drug, it is recommended to dissolve the drug in the vial (to add to the bottle 1-2 teaspoons of water).
The resulting slurry used internally (orally - through the mouth) or for vaginal irrigations, or for the impregnation of tampons for intravaginal administration.
•in the treatment of DCI (dysentery, salmonellosis, food poisoning, etc.), and 1 dose (1 teaspoon) 2 times a day for 5-7 days (ingestion);
•aftercare convalescents OKI 1 dose (1 teaspoon) 2 times a day for 5 days (oral);
•when intestinal dysbiosis - 1 dose (1 teaspoon) 2-3 times daily for 10-20 days (ingestion);
•in the treatment of chronic aphthous stomatitis in 2 doses (2 teaspoons) 2 times a day for 14 days (orally after eating and rinsing mouth).
•in the treatment of the OKA - 2 doses (2 teaspoons) 3 times a day for 5-7 days (ingestion);
•aftercare convalescents after OKI 2 doses (2 teaspoons) 2 times a day for 5 days, if necessary up to 2 weeks (oral);
•for the prevention of purulent-septic complications in the postoperative period - 2 doses (2 teaspoons) 2 times a day for 5-7 days before surgery and for 2 doses (2 teaspoons) 2 times a day for 10 days after surgery (oral);
•for the treatment of vulvovaginal candidiasis and bacterial vaginosis - 2 doses (2 teaspoons) 1 times a day for 5-10 days in the form of irrigation and applications with exposure 6-12 hours. After ingestion do not eat or drink for 40-60 minutes.
Oral drug zastosowanie for 30-40 min before meal. If necessary, repeated treatment is possible.
It is not revealed.
Is not installed.
The diluted drug must not be stored.
Application of pregnancy and breastfeeding. The drug is used during pregnancy and breastfeeding.
Interaction with other drugs
Has not been studied. Overdose. Has not been studied.
Impact on driving ability
The drug does not affect the ability to drive.
Store in a dry, protected from light place, at temperatures not above 25 °C. Keep out of reach of children.
Shelf life. 3 years.